A case of Kimura disease with atopic dermatitis successfully treated with baricitinib
Marina Ueda
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorCorresponding Author
Toshiaki Kogame
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Correspondence
Toshiaki Kogame, Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Email: [email protected]
Search for more papers by this authorGyohei Egawa
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorNaotomo Kambe
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorKenji Kabashima
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorMarina Ueda
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorCorresponding Author
Toshiaki Kogame
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Correspondence
Toshiaki Kogame, Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Email: [email protected]
Search for more papers by this authorGyohei Egawa
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorNaotomo Kambe
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorKenji Kabashima
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this author
REFERENCES
- 1Katagiri K, Itami S, Hatano Y, Yamaguchi T, Takayasu S. In vivo expression of IL-4, IL-5, IL-13 and IFN-gamma mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura's disease. Br J Dermatol. 1997; 137: 972–7.
- 2Huang HY, Yang CY, Yao WT, Chen YF, Yu CM, Tung KY, et al. Kimura disease of the thigh treated with surgical excision and dupilumab. Ann Plast Surg. 2022; 88(1s Suppl 1): S110–3.
- 3Xie DP, Xu YF, Li MQ. Kimura's disease presenting as scrotal mass: a difficult diagnosis. Urol J. 2018; 15: 295–6.
- 4Ye P, Wei T, Yu GY, Wu LL, Peng X. Comparison of local recurrence rate of three treatment modalities for Kimura disease. J Craniofac Surg. 2016; 27: 170–4.
- 5Al Shammari F, Nasiri A, Alkhathami M, Alawfi F, Alfifi M, Al Otaibi E. Mepolizumab as an effective treatment for Kimura's disease associated with ulcerative colitis: a case report. J Family Med Prim Care. 2019; 8: 3028–31.
